Sigyn Therapeutics, Inc. (SIGY)
0.025
0.00 (0.00%)
USD |
OTCM |
Apr 02, 16:00
Sigyn Therapeutics EPS Diluted (Quarterly) : -0.3604 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| LadRx Corp. | -1.453 |
| GeneLink, Inc. | -- |
| Cantabio Pharmaceuticals, Inc. | -- |
| Affymax, Inc. | -- |
| America Great Health | 0.00 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.5785M |
| Total Expenses (Quarterly) | 0.5785M |
| Enterprise Value | 2.769M |
| Earnings Yield | -9.63K% |
| Normalized Earnings Yield | -9764.16 |